CASK and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss: In this study, CASK demonstrated a remarkable reduction in gene expression in SBS patients compared to healthy controls and an increased gene expression in SBS patients treated with teduglutide (Table 3) and its characteristic protein localization was confirmed by IHC (Figure 4C).